Fred Alger Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Fred Alger Management's BLUE Position: Q3 2020 in Review
Fred Alger Management sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 386 shares — an estimated $305K sold.
Fred Alger Management first reported a position in BLUE in Q4 2013 and held it in 25 quarters. The position peaked at $26.7M in Q2 2015. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.
- Fred Alger Management reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
- Fred Alger Management sold 386 bluebird bio shares in Q3 2020, an estimated $305K.
- Fred Alger Management first reported a position in bluebird bio in Q4 2013 and held it in 25 quarters.
- Fred Alger Management's bluebird bio position peaked at $26.7M in Q2 2015.
- 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.
Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.